Affiner les résultats

Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial

Behringer, K. ; Thielen, I. ; Mueller, H. ; Goergen, H. ; Eibl, A. D. ; Rosenbrock, J. ; Halbsguth, T. ; Eichenauer, D. A. ; Fuchs, M. ; Reiners, K. S. ; Renno, J. H. ; van der Ven, K. ; Kuehr, M. ; von Wolff, M. ; Diehl, V. ; Engert, A. ; Borchmann, P.

In: Annals of Oncology, 2012, vol. 23, no. 7, p. 1818-1825

An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma

Hay, A. E. ; Klimm, B. ; Chen, B. E. ; Goergen, H. ; Shepherd, L. E. ; Fuchs, M. ; Gospodarowicz, M. K. ; Borchmann, P. ; Connors, J. M. ; Markova, J. ; Crump, M. ; Lohri, A. ; Winter, J. N. ; Dörken, B. ; Pearcey, R. G. ; Diehl, V. ; Horning, S. J. ; Eich, H. T. ; Engert, A. ; Meyer, R. M.

In: Annals of Oncology, 2013, vol. 24, no. 12, p. 3065-3069

Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group

Klimm, B. ; Eich, HT ; Haverkamp, H. ; Lohri, A. ; Koch, P. ; Boissevain, F. ; Trenn, G. ; Worst, P. ; Dühmke, E. ; Müller, RP ; Müller-Hermelink, K. ; Pfistner, B. ; Diehl, V. ; Engert, A.

In: Annals of Oncology, 2006, vol. 18, no. 2, p. 357-363

The recent decline in mortality from Hodgkin lymphomas in central and eastern Europe

Bosetti, C. ; Levi, F. ; Ferlay, J. ; Lucchini, F. ; Negri, E. ; La Vecchia, C.

In: Annals of Oncology, 2008, vol. 20, no. 4, p. 767-774

Richter syndrome

Condoluci, Adalgisa ; Rossi, Davide

In: Current Oncology Reports, 2021, vol. 23, no. 3, p. 10

Purpose of Review Richter syndrome (RS) is an uncommon but aggressive evolution of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). RS is an unmet clinical need in the field of CLL. Recent advances in understanding the biology of this condition provide the rationale for testing new therapeutic concepts in order to improve the outcome of patients developing RS, which is so far...